StephenCarlMathaiMDMHS
Pulmonology • Baltimore, MDPulmonary Vascular Medicine
Associate Professor of Medicine Johns Hopkins University School of Medicine
Dr. Mathai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1830 E. Monument Street
1830 Building 5th Floor Pulmonary
Baltimore, MD 21287Phone+1 410-550-5864- Is this information wrong?
Summary
- Dr. Stephen Mathai is a pulmonologist in Baltimore, MD and is affiliated with multiple hospitals in the area, including Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center. He received his medical degree from Sidney Kimmel Medical College and has been in practice 18 years. He specializes in pulmonary hypertension and is experienced in critical care medicine and pulmonary medicine.
Education & Training
Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2008
Johns Hopkins Bloomberg School of Public HealthMHS, Clinical Investigation, 2003 - 2005
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1999 - 2003- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1999
Certifications & Licensure
MD State Medical License 2003 - 2025
PA State Medical License 2000 - 2004
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01
- Sildenafil for Early Pulmonary Vascular Disease in Scleroderma Start of enrollment: 2021 Sep 20
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Health-Related Quality of Life Across the Spectrum of Pulmonary Hypertension.Balasubramanian, A., Larive, B., Horn, E., DuBrock, H., Mehra, R., Jacob, M., Hemnes, A., Leopold, J., Radeva, M., Hill, N., Erzurum, S., Berman-Rosenzweig, E., Frantz...> ;Chest. 2024 Feb 12
- Ambitions for Pulmonary Arterial Hypertension Composite End Points: A Chain Is Only as Strong as Its Weakest Link.Zelt, J., Weatherald, J., Mathai, S.> ;Chest. 2023 Dec 1
- Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertension.Catherine E Simpson, Anjira S Ambade, Robert Harlan, Aurelie Roux, Susan Aja, David Graham, Ami A Shah, Laura K Hummers, Anna R Hemnes, Jane A Leopold, Evelyn M Horn, ...> ;American Journal of Physiology. Lung Cellular and Molecular Physiology. 2023 Nov 1
- Join now to see all
Press Mentions
- United Therapeutics Highlights Poster Presentations from the Recent CHEST 2020 MeetingOctober 22nd, 2020
More Research, Advocacy Can Improve PAH DisparitiesNovember 14th, 2023
Grant Support
- Neurohormonal Activation In Scleroderma-Related Pulmonary Arterial HypertensionNational Heart, Lung, And Blood Institute2009–2011
- Prognostic Factors, Genetics, And Therapy In Pah-SsdNational Heart, Lung, And Blood Institute2006
Hospital Affiliations
Johns Hopkins HospitalBaltimore, Maryland
The Johns Hopkins HospitalBaltimore, Maryland
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/stephen-mathai
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
